Trial Profile
Safety and efficacy of dapagliflozin versus other therapies in combination with metformin in patients with type 2 diabetes mellitus: A retrospective real-world study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Dec 2019
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary) ; Metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 19 Jul 2017 New trial record
- 13 Jun 2017 Results presented at the 77th Annual Scientific Sessions of the American Diabetes Association